[1] Conlon JM,Yano K,Waugh D,et al.Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J].JExp Zool,1996,275(2-3):226-38. [2] Ames RS,Sarau HM,ChambersJK,et al.Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401 (6750):282-6. [3] Douglas SA,Tayara L,Ohlstein EH,et al.Congestive heart failure and expression of myocardial urotensin Ⅱ [J].Lancet,2002,359(9322):1990-7. [4] Richards AM,Nicholls MG,LainchburyJG,et al.Plasma urotensin Ⅱ in heart failure[J].Lancet,2002,360(9332):545-6. [5] Ng LL,Loke I,O’Brien RJ,et al.Plasma urotensin in human systolic heart failure[J].Circulation,2002,106(23):2877-80. [6] Tzanidis A,Harman RD,Thomas WG,et al.Derect actions of urotensin Ⅱ on the heart:implications for cadiac fibrosis and hypertrophy[J].Circ Res,2003,93(3):246-53. [7] 钟萍,李志梁,吴宏超,等.充血性CHF患者血浆尾加压素Ⅱ变化的临床研究[J].第一军医大学学报,2003,23(2):121-3.Zhong P,Li ZL,Wu HC,et al.Clinical study of changes of urotensin Ⅱ in patients with congestive heart failure [J].JFirst Mil Med Univ/Di YiJun Yi Da Xue Xue Bao,2003,23(2):121-3. [8] Paul S,Shoshana S.Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells [J].Cir Res,1982,50(1):101-16. [9] Sarka CJ,Psotova M.Neonatal rat cardiomyocytes-a model for the study of morphological,biochemical and electrophysiological characteristics of the heart [J].Biomed Pap Mea Fac Univ Palacky Olomouc Czech Repub,2001,145(2):49-55. [10] Rajapurohitam V,Gan XT,Kirshenbaum LA,et al.The obesityassociated peptide leptin induces hypertyophy in neonatal rat ventricular myocytes[J].Cir Res,2003,93(4):277-9. [11] 宋平根,李素文.流式细胞术的原理和应用[M].北京师范大学出版社,1992.10-3. [12] 杨俊娟,林文华,张勇刚,等.冠状动脉粥样硬化及其介入治疗后血浆尾加压素Ⅱ水平变化的研究[J].中国老年心脑血管病杂志,2001,3(6):373-5.YangJJ,Lin WH,Zhang YG,et al.Study on the changes of plasma urotensin Ⅱ level in coronary atherosclerosis and coronary heart diseases after angioplasty [J].ChinJCeriatr Cardiovasc Cerebrovasc Dis,2001,3(6):373-5. [13] 曹军,张勇刚,齐永芬,等.血浆尾加压素Ⅱ含量在几种疾病中的变化[J].放射免疫学杂志,2001,14(4):195-7.CaoJ,Zhang YG,Qi YF,et al.Alteration of plasma urotensin Ⅱ in several diseases[J].JRadioimmunol,2001,14(4):195-7. [14] 曹军,张勇刚,杨军,等.大鼠主动脉球囊成形术后尾加压素Ⅱ受体的变化[J].中国病理生理杂志,2001,17(7):593-7.CaoJ,Zhang YG,YangJ,et al.The alteration of urotensin-Ⅱ receptors in rat aorta after balloon angioplasty injury[J].ChinJPathophysiol,2001,17(7):593-7. [15] 涂晓文,刘映峰,李志樑,等.尾加压素Ⅱ在冠状动脉中的表达与冠状动脉粥样硬化[J].第一军医大学学报,2003,23(6):572-4.Tu XW,Liu YF,Li ZL,et al.Expression of urotensin Ⅱ in humancoronary artery and coronary atherosclerosis [J].JFirst Mil Med Univ/Di YiJun Yi Da Xue Xue Bao,2003,23(6):572-4. |